TITLE:
Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)

CONDITION:
Migraine

INTERVENTION:
MK0462, rizatriptan benzoate / Duration of Treatment: 1day

SUMMARY:

      The purpose of this study is to test the effectiveness of an approved drug in the early
      treatment of migraine.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Six month history of migraine; attacks typically mild when they begin with 1-4
             migraine attacks per month.

        Exclusion Criteria:

          -  Heart disease

          -  High blood pressure
      
